Results 161 to 170 of about 821,529 (204)
Some of the next articles are maybe not open access.
ACS Nano, 2021
The dissemination of tumor metastasis in the peritoneal cavity, also called peritoneal metastasis (PM) or carcinomatosis, represents a late stage of gastrointestinal and gynecological cancer with very poor prognosis, even when cytoreductive surgery is ...
A. Pinto +9 more
semanticscholar +1 more source
The dissemination of tumor metastasis in the peritoneal cavity, also called peritoneal metastasis (PM) or carcinomatosis, represents a late stage of gastrointestinal and gynecological cancer with very poor prognosis, even when cytoreductive surgery is ...
A. Pinto +9 more
semanticscholar +1 more source
PIPAC for Advanced Peritoneal Metastasis
2021Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel and advanced tool for the treatment of peritoneal metastasis. Due in part to the invasiveness of CRS/HIPEC and the often aggressive biology or advanced stage of peritoneal metastasis, it has become increasingly recognized that the risks of any intervention need to be carefully weighed ...
Kuno Lehmann +5 more
openaire +1 more source
ACS Nano, 2021
Peritoneal metastasis (PM) is considered as the terminal stage of metastatic colon cancer, with still poor median survival rate even with the best recent chemotherapy treatment.
Vladimir Mulens-Arias +7 more
semanticscholar +1 more source
Peritoneal metastasis (PM) is considered as the terminal stage of metastatic colon cancer, with still poor median survival rate even with the best recent chemotherapy treatment.
Vladimir Mulens-Arias +7 more
semanticscholar +1 more source
Mechanisms of Peritoneal Metastasis Formation
2020Mechanisms of peritoneal metastasis (PM) formation remain unclear. It has long been considered that the establishment of PM is a multi-step process. Here are the recent new concepts of the formation of PM, in terms of three patterns of PM: trans-mesothelial, trans-lymphatic, and superficial growing metastasis.
Yutaka Yonemura +13 more
openaire +1 more source
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Journal of Visualized Experiments, 2016Epithelial ovarian cancer (EOC) is the leading cause of death from gynecologic malignancy in the United States. Mortality is due to diagnosis of 75% of women with late stage disease, when metastasis is already present. EOC is characterized by diffuse and widely disseminated intra-peritoneal metastasis.
Kyle A, Lewellen +3 more
openaire +2 more sources
Peritoneal Tumour DNA in Peritoneal Fluid: Emerging Tool for Peritoneal Metastasis Detection
Journal of Gastrointestinal CancerThe prognostic significance of positive peritoneal cytology still varied between cancer types and geographical origin. However, because of the lack of sensitivity of this biomarker, conventional cytology is not routinely performed in every country. Here, we wanted to test a new biomarker, peritoneal tumour DNA, using NGS technique, in order to compare ...
Antoine, Mariani +5 more
openaire +2 more sources
Peritoneal Metastasis of Retroperitoneal Tumors
2017Introduction Peritoneal metastases of retroperitoneal tumors are in general rare. They can arise as synchronous peritoneal seeding of the primary tumor or as a tumor recurrence after surgery affecting the peritoneum. This review illustrates the different retroperitoneal tumor etiologies which can present peritoneal surface malignancies and is ...
Andreas Brandl +2 more
openaire +1 more source
Rationale of Treatment for Peritoneal Metastasis.
Gan to kagaku ryoho. Cancer & chemotherapy, 2023In 1998, the Peritoneal Surface Oncology Group International(PSOGI)proposed a novel treatment referred to as comprehensive treatment(COMPT). COMPT involves the complete removal of macroscopic tumors(cytoreductive surgery: CRS) and eradication of micrometastasis(MM)with neoadjuvant chemotherapy(NAC)plus intraoperative hyperthermic intraperitoneal ...
Yutaka, Yonemura +12 more
openaire +1 more source
Nanomotor-driven precision therapy for peritoneal metastasis
BiomaterialsPeritoneal metastasis (PM) is a terminal stage of gastrointestinal cancers, often resulting in poor survival outcomes. Traditional treatments like cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have shown some effectiveness but are associated with significant risks.
Yaoguang She +8 more
openaire +2 more sources

